Growth Metrics

Collegium Pharmaceutical (COLL) Deferred Taxes (2021 - 2026)

Collegium Pharmaceutical has reported Deferred Taxes over the past 5 years, most recently at -$10.1 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 0.83% year-over-year to -$10.1 million; the TTM value through Dec 2025 reached -$25.7 million, up 4.31%, while the annual FY2025 figure was -$25.7 million, 4.31% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$10.1 million at Collegium Pharmaceutical, up from -$12.1 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $2.1 million in Q3 2022 and troughed at -$62.6 million in Q2 2021.
  • A 5-year average of -$7.4 million and a median of -$3.4 million in 2022 define the central range for Deferred Taxes.
  • Biggest five-year swings in Deferred Taxes: surged 656.23% in 2022 and later plummeted 9491.3% in 2024.
  • Year by year, Deferred Taxes stood at -$15.0 million in 2021, then soared by 92.82% to -$1.1 million in 2022, then skyrocketed by 68.65% to -$338000.0 in 2023, then tumbled by 2904.73% to -$10.2 million in 2024, then rose by 0.83% to -$10.1 million in 2025.
  • Business Quant data shows Deferred Taxes for COLL at -$10.1 million in Q4 2025, -$12.1 million in Q3 2025, and -$2.9 million in Q2 2025.